The Current Strategy for Managing Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1

Gut and Liver - South Korea
doi 10.5009/gnl.2012.6.3.287
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Editorial Office of Gut and Liver

Related search

Pasireotide (SOM230) Is Effective for the Treatment of Pancreatic Neuroendocrine Tumors (PNETs) in a Multiple Endocrine Neoplasia Type 1 (MEN1) Conditional Knockout Mouse Model

Surgery
Surgery
2012English

Multiple Endocrine Neoplasia Type 1

2020English

Non-Functioning Pancreatic Neuroendocrine Tumor in a Patient With Multiple Endocrine Neoplasia Type 1 Syndrome: Case Report

Universal Journal of Public Health
2019English

Osteoporosis in Multiple Endocrine Neoplasia Type 1

Archives of Surgery
1999English

Natural Course of Small, Asymptomatic Neuroendocrine Pancreatic Tumours in Multiple Endocrine Neoplasia Type 1: An Endoscopic Ultrasound Imaging Study

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2006English

Long-Term Outcomes in Patients With Multiple Endocrine Neoplasia Type 1 and Pancreaticoduodenal Neuroendocrine Tumours

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2016English

Multiple Endocrine Neoplasia Type 4

2020English

Tissue Selectivity in Multiple Endocrine Neoplasia Type 1-Associated Tumorigenesis

Cancer Research
Cancer ResearchOncology
2009English

Sporadic Multiple Endocrine Neoplasia Type 2A

Internal Medicine
Internal MedicineMedicine
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy